LINCOLN PHARMACEUTICALS
Back to Balance Sheet
|
LINCOLN PHARMACEUTICALS Last 5 Year Long Term Provisions History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Long Term Provisions | ₹0.10 Cr | ₹25 Cr | - | ₹16 Cr | ₹33 Cr |
What is the latest Long Term Provisions ratio of LINCOLN PHARMACEUTICALS ?
Year | Long Term Provisions |
---|---|
Mar2024 | ₹0.10 Cr |
Mar2023 | ₹25 Cr |
Mar2022 | - |
Mar2021 | ₹16 Cr |
Mar2020 | ₹33 Cr |
How is Long Term Provisions of LINCOLN PHARMACEUTICALS Trending?
Years | Long Term Provisions | % Change | |
---|---|---|---|
Mar2024 | ₹0.10 Cr | -99.62 | |
Mar2023 | ₹25 Cr | 0 | |
Mar2022 | - | -100.00 | |
Mar2021 | ₹16 Cr | -50.86 | |
Mar2020 | ₹33 Cr | - |
Compare Long Term Provisions of peers of LINCOLN PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
LINCOLN PHARMACEUTICALS | ₹1,569.8 Cr | -3.8% | 24.7% | 31.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹441,838.0 Cr | 1% | 4.6% | 47.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹156,107.0 Cr | 1% | -3.2% | 59.3% | Stock Analytics | |
CIPLA | ₹120,270.0 Cr | -1.1% | -0.3% | 20.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹113,077.0 Cr | 2.2% | 12.1% | 21.6% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹96,553.2 Cr | -2.7% | 0.8% | 43.8% | Stock Analytics |
LINCOLN PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
LINCOLN PHARMACEUTICALS | -3.8% |
24.7% |
31.4% |
SENSEX | -2.1% |
-2% |
11.3% |
You may also like the below Video Courses